A Real-World Exploration into Clinical Outcomes of Direct Oral Anticoagulant Dosing Regimens in Morbidly Obese Patients Using Data-Driven Approaches
EM Nwanosike, W Sunter, MA Ansari… - American Journal of …, 2023 - Springer
Introduction The clinical outcomes of direct oral anticoagulant (DOAC) dosage regimens in
morbid obesity are uncertain due to limited clinical evidence. This study seeks to bridge this …
morbid obesity are uncertain due to limited clinical evidence. This study seeks to bridge this …
A real-world exploration into clinical outcomes of direct oral anticoagulant dosing regimens in morbidly obese patients using data-driven approaches
EM Nwanosike, W Sunter, MA Ansari… - American Journal of …, 2023 - eprints.soton.ac.uk
INTRODUCTION: The clinical outcomes of direct oral anticoagulant (DOAC) dosage
regimens in morbid obesity are uncertain due to limited clinical evidence. This study seeks …
regimens in morbid obesity are uncertain due to limited clinical evidence. This study seeks …
A Real-World Exploration into Clinical Outcomes of Direct Oral Anticoagulant Dosing Regimens in Morbidly Obese Patients Using Data-Driven Approaches
E Nwanosike, W Sunter, MA Ansari… - American Journal of …, 2023 - pure.hud.ac.uk
Introduction: The clinical outcomes of direct oral anticoagulant (DOAC) dosage regimens in
morbid obesity are uncertain due to limited clinical evidence. This study seeks to bridge this …
morbid obesity are uncertain due to limited clinical evidence. This study seeks to bridge this …
A Real-World Exploration into Clinical Outcomes of Direct Oral Anticoagulant Dosing Regimens in Morbidly Obese Patients Using Data-Driven Approaches.
EM Nwanosike, W Sunter, MA Ansari… - American Journal of …, 2023 - europepmc.org
Method A data-driven observational study was carried out using supervised machine
learning (ML) models with a dataset extracted from electronic health records and …
learning (ML) models with a dataset extracted from electronic health records and …
A Real-World Exploration into Clinical Outcomes of Direct Oral Anticoagulant Dosing Regimens in Morbidly Obese Patients Using Data-Driven Approaches
EM Nwanosike, W Sunter, MA Ansari… - … devices, and other …, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction The clinical outcomes of direct oral anticoagulant (DOAC) dosage regimens in
morbid obesity are uncertain due to limited clinical evidence. This study seeks to bridge this …
morbid obesity are uncertain due to limited clinical evidence. This study seeks to bridge this …